Valrubicin Pregnancy and Breastfeeding Warnings
Valrubicin is also known as: Valstar
Valrubicin Pregnancy Warnings
Valrubicin has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of embryotoxicity and teratogenicity. There are no controlled data in human pregnancy. The drug is only recommended for use during pregnancy if the potential benefit justifies the potential risk.
The manufacturer has recommended that all patients (both male and female) of reproductive age be advised to use an effective method of contraception during the treatment period.
Valrubicin Breastfeeding Warnings
There are no data on the excretion of valrubicin into human milk. Because the drug is highly lipophilic and any exposure of infants to valrubicin could pose a serious health risk, discontinuation of nursing before the initiation of valrubicin therapy is recommended.
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.